HepaStem seems most promising pipeline agent for decompensated cirrhosis due to NASH: GlobalData Read more
Redx will become a key upcoming player in IPF treatment with FDA’s ODD for zelasudil: GlobalData Read more
Crohn’s disease treatment market sees major shift with biosimilars and next-gen therapies: GlobalData Read more